Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Prednisone for ANCA-Associated Vasculitis Remission Maintenance
NCT03290456Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2019
- Primary completion
- Oct 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) comparing Prednisone Extended with Placebo Extended (2 arms). Primary endpoint: Relapse-free survival at 30 months. Started Aug 2019; status: recruiting.
02
Drugs
prednisone
03
Conditions
granulomatosis with polyangiitis (GPA)microscopic polyangiitis (MPA)
Beyond the preview
Go deeper on NCT03290456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290456.